Effectiveness of sotalol treatment in symptomatic Brugada syndrome

American Journal of Cardiology

Volumn 93, Issue 10, 2004, Pages 1320-1322

  Glatter, Kathryn A ^a   Wang, Qing ^b   Keating, Mark ^b   Chen, Shenghan ^b   Chiamvimonvat, Nipavan ^b   Scheinman, Melvin M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL; SOTALOL;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DRUG EFFICACY; FAMILY HISTORY; GENE MUTATION; GENETICS; HUMAN; MALE; PRIORITY JOURNAL; SYMPTOM; SYNCOPE;

ADULT; ANTI-ARRHYTHMIA AGENTS; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; SOTALOL; SYNDROME; VENTRICULAR FIBRILLATION;

EID: 2342458202     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.02.023     Document Type: Article

References (14)

1. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death. J Am Coll Cardiol. 20:1992;1391-1396
2. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., Potenza D., Moya A., Borggrefe M., Breithardt G., et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature. 392:1998;393-396
3. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della Bella P., Giordano U., Bloise R., Giustetto C., De Nardis R., Grillo M., et al. Natural history of Brugada syndrome. Insights for risk stratification and management. Circulation. 105:2002;1342-1347
4. Brugada J., Brugada R., Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3. Circulation. 97:1998;457-460
5. Brugada J., Brugada R., Antzelevitch C., Towbin J., Nademanee K., Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 105:2002;73-78
6. Antzelevitch C., Brugada P., Brugada J., Brugada R., Shimizu W., Gussak I., Riera A.R.P. Brugada syndrome. A decade of progress. Circ Res. 91:2002;1114-1118
7. Brugada R., Brugada J., Antzelevitch C., Kirsch G.E., Potenza D., Towbin J.A., Brugada P. Sodium channel blockers identify risk for sudden death in patients with ST-elevation and right bundle branch block but structurally normal hearts. Circulation. 101:2000;510-515
8. Naccarelli G.V., Antzelevitch C. The Brugada syndrome. Am J Med. 110:2001;573-581
9. Alings M., Wilde A. "Brugada" syndrome. Clinical data and suggested pathophysiological mechanism. Circulation. 99:1999;666-673
10. Belhassen B., Viskin S., Fish R., Glick A., Setbon I., Eldar M. Effects of EP-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol. 10:1999;1301-1312
11. Miyazaki T., Mitamura H., Miyoshi S., Soejima K., Aizawa Y., Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 26:1996;1061-1070
12. Feng J., Wang Z., Li G.R., Nattel S. Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther. 281:1997;384-392
13. Yan G.X., Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 100:1999;1660-1666
14. Kakishita M., Kurita T., Matsuo K., Taguchi A., Suyama K., Shimizu W., Aihara N., Kamakura S., Yamamoto F., Kobayashi J., Kosakai Y., Ohe T. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by ICD therapy. J Am Coll Cardiol. 36:2000;1646-1653